-
1
-
-
0032852528
-
Molecular and biological properties of vascular endothelial growth factor
-
Ferrara N. Molecular and biological properties of vascular endothelial growth factor. J Mol Med. 1999; 77: 527-543.
-
(1999)
J Mol Med
, vol.77
, pp. 527-543
-
-
Ferrara, N.1
-
2
-
-
0021978223
-
Tumor angiogenesis
-
Folkman J. Tumor angiogenesis. Adv. Cancer Res. 1985; 43: 175-203.
-
(1985)
Adv. Cancer Res
, vol.43
, pp. 175-203
-
-
Folkman, J.1
-
3
-
-
0035793623
-
Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants
-
Gille H, Kowalski J, Li B, LeCouter J, Moffat B, Zioncheck TF, Pelletier N, Ferrara N. Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants. J Biol Chem. 2001; 276: 3222-3230.
-
(2001)
J Biol Chem
, vol.276
, pp. 3222-3230
-
-
Gille, H.1
Kowalski, J.2
Li, B.3
LeCouter, J.4
Moffat, B.5
Zioncheck, T.F.6
Pelletier, N.7
Ferrara, N.8
-
4
-
-
0033556287
-
A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases
-
Meyer M, Clauss M, Lepple-Wienhues A, Waltenberger J, Augustin HG, Ziche M, Lanz C, Buttner M, Rziha HJ, Dehio C. A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases. EMBO J. 15-1-1999; 18: 363-374.
-
EMBO J. 15-1-1999
, vol.18
, pp. 363-374
-
-
Meyer, M.1
Clauss, M.2
Lepple-Wienhues, A.3
Waltenberger, J.4
Augustin, H.G.5
Ziche, M.6
Lanz, C.7
Buttner, M.8
Rziha, H.J.9
Dehio, C.10
-
5
-
-
24644434383
-
Targeting angiogenesis with antibodies for the treatment of cancer
-
Andreasson P, Carlsson R. Targeting angiogenesis with antibodies for the treatment of cancer. IDrugs. 2005; 8: 730-733.
-
(2005)
IDrugs
, vol.8
, pp. 730-733
-
-
Andreasson, P.1
Carlsson, R.2
-
6
-
-
7444261960
-
Use of soluble recombinant decoy receptor vascular endothelial growth factor trap (VEGF Trap) to inhibit vascular endothelial growth factor activity
-
Konner J, Dupont J. Use of soluble recombinant decoy receptor vascular endothelial growth factor trap (VEGF Trap) to inhibit vascular endothelial growth factor activity. Clin Colorectal Cancer. 2004; 4(Suppl 2): S81-S85.
-
(2004)
Clin Colorectal Cancer
, vol.4
, Issue.SUPPL. 2
-
-
Konner, J.1
Dupont, J.2
-
7
-
-
6444225129
-
VGA1155, a novel binding antagonist of VEGF, inhibits angiogenesis in vitro and in vivo
-
Ueda Y, Yamagishi T, Ikeya H, Hirayama N, Itokawa T, Aozuka Y, Samata K, Nakaike S, Tanaka M, Ono M, Saiki I. VGA1155, a novel binding antagonist of VEGF, inhibits angiogenesis in vitro and in vivo. Anticancer Res. 2004; 24: 3009-3017.
-
(2004)
Anticancer Res
, vol.24
, pp. 3009-3017
-
-
Ueda, Y.1
Yamagishi, T.2
Ikeya, H.3
Hirayama, N.4
Itokawa, T.5
Aozuka, Y.6
Samata, K.7
Nakaike, S.8
Tanaka, M.9
Ono, M.10
Saiki, I.11
-
8
-
-
0037102369
-
ZD6474 inhibits vascular endothelial growth factor signaling, angiogenesis, and tumor growth following oral administration
-
Wedge SR, Ogilvie DJ, Dukes M, Kendrew J, Chester R, Jackson JA, Boffey SJ, Valentine PJ, Curwen JO, Musgrove HL, Graham JA, Hughes GD, Thomas AP, Stokes ES, Curry B, Richmond GH, Wadsworth PF, Bigley AL, Hennequin LF. ZD6474 inhibits vascular endothelial growth factor signaling, angiogenesis, and tumor growth following oral administration. Cancer Res. 2002; 62: 4645-4655.
-
(2002)
Cancer Res
, vol.62
, pp. 4645-4655
-
-
Wedge, S.R.1
Ogilvie, D.J.2
Dukes, M.3
Kendrew, J.4
Chester, R.5
Jackson, J.A.6
Boffey, S.J.7
Valentine, P.J.8
Curwen, J.O.9
Musgrove, H.L.10
Graham, J.A.11
Hughes, G.D.12
Thomas, A.P.13
Stokes, E.S.14
Curry, B.15
Richmond, G.H.16
Wadsworth, P.F.17
Bigley, A.L.18
Hennequin, L.F.19
-
9
-
-
20144370978
-
AZ D2171:a highly potent, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for the treatment of cancer
-
Wedge SR, Kendrew J, Hennequin LF, Valentine PJ, Barry ST, Brave SR, Smith NR, James NH, Dukes M, Curwen JO, Chester R, Jackson JA, Boffey SJ, Kilburn LL, Barnett S, Richmond GH, Wadsworth PF, Walker M, Bigley AL, Taylor ST, Cooper L, Beck S, Jurgensmeier JM, Ogilvie DJ. AZ D2171:a highly potent, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for the treatment of cancer. Cancer Res.2005; 65: 4389-4400.
-
(2005)
Cancer Res
, vol.65
, pp. 4389-4400
-
-
Wedge, S.R.1
Kendrew, J.2
Hennequin, L.F.3
Valentine, P.J.4
Barry, S.T.5
Brave, S.R.6
Smith, N.R.7
James, N.H.8
Dukes, M.9
Curwen, J.O.10
Chester, R.11
Jackson, J.A.12
Boffey, S.J.13
Kilburn, L.L.14
Barnett, S.15
Richmond, G.H.16
Wadsworth, P.F.17
Walker, M.18
Bigley, A.L.19
Taylor, S.T.20
Cooper, L.21
Beck, S.22
Jurgensmeier, J.M.23
Ogilvie, D.J.24
more..
-
10
-
-
0034655182
-
-
Wood JM, Bold G, Buchdunger E, Cozens R, Ferrari S, Frei J, Hofmann F, Mestan J, Mett H, O'Reilly T, Persohn E, Rosel J, Schnell C, Stover D, Theuer A, Towbin H, Wenger F, Woods-Cook K, Menrad A, Siemeister G, Schirner M, Thierauch KH, Schneider MR, Drevs J, Martiny-Baron G, Totzke F. PTK787/ZK 222584,a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration. Cancer Res. 2000; 60: 2178-2189.
-
Wood JM, Bold G, Buchdunger E, Cozens R, Ferrari S, Frei J, Hofmann F, Mestan J, Mett H, O'Reilly T, Persohn E, Rosel J, Schnell C, Stover D, Theuer A, Towbin H, Wenger F, Woods-Cook K, Menrad A, Siemeister G, Schirner M, Thierauch KH, Schneider MR, Drevs J, Martiny-Baron G, Totzke F. PTK787/ZK 222584,a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration. Cancer Res. 2000; 60: 2178-2189.
-
-
-
-
11
-
-
7444224685
-
Integrating the anti-VEGF-A humanized monoclonal antibody bevacizumab with chemotherapy in advanced colorectal cancer
-
Hurwitz H. Integrating the anti-VEGF-A humanized monoclonal antibody bevacizumab with chemotherapy in advanced colorectal cancer. Clin Colorectal Cancer. 2004; 4(Suppl 2): S62-S68.
-
(2004)
Clin Colorectal Cancer
, vol.4
, Issue.SUPPL. 2
-
-
Hurwitz, H.1
-
12
-
-
0033146795
-
Vascular endothelial growth factor and microvascular permeability
-
Bates DO, Lodwick D, Williams B. Vascular endothelial growth factor and microvascular permeability. Microcirculation. 1999; 6: 83-96.
-
(1999)
Microcirculation
, vol.6
, pp. 83-96
-
-
Bates, D.O.1
Lodwick, D.2
Williams, B.3
-
13
-
-
8844245012
-
AZD2171 and ZD6474, VEGF signalling inhibitors, significantly reduce tumour vascular permeability in a human SW620 xenograft as detected by macro-molecular dynamic contrast enhanced MRI
-
Bradley D, Tessier JJ, Checkley D, Kuribayashi H, Waterton JC, Wedge SR. AZD2171 and ZD6474, VEGF signalling inhibitors, significantly reduce tumour vascular permeability in a human SW620 xenograft as detected by macro-molecular dynamic contrast enhanced MRI. Proc. Intl. Soc. Mag. Reson. Med. 2004; 121.
-
(2004)
Proc. Intl. Soc. Mag. Reson. Med
, pp. 121
-
-
Bradley, D.1
Tessier, J.J.2
Checkley, D.3
Kuribayashi, H.4
Waterton, J.C.5
Wedge, S.R.6
-
14
-
-
0346752528
-
Use of dynamic contrast-enhanced MRI to evaluate acute treatment with ZD6474, a VEGF signalling inhibitor, in PC-3 prostate tumours
-
Checkley D, Tessier JJ, Kendrew J, Waterton JC, Wedge SR. Use of dynamic contrast-enhanced MRI to evaluate acute treatment with ZD6474, a VEGF signalling inhibitor, in PC-3 prostate tumours. Br J Cancer. 2003; 89: 1889-1895.
-
(2003)
Br J Cancer
, vol.89
, pp. 1889-1895
-
-
Checkley, D.1
Tessier, J.J.2
Kendrew, J.3
Waterton, J.C.4
Wedge, S.R.5
-
15
-
-
0037099598
-
PTK787/ ZK 222584,a specific vascular endothelial growth factor-receptor tyrosine kinase inhibitor, affects the anatomy of the tumor vascular bed and the functional vascular properties as detected by dynamic enhanced magnetic resonance imaging
-
Drevs J, Muller-Driver R, Wittig C, Fuxius S, Esser N, Hugenschmidt H, Konerding MA, Allegrini PR, Wood J, Hennig J, Unger C, Marme D. PTK787/ ZK 222584,a specific vascular endothelial growth factor-receptor tyrosine kinase inhibitor, affects the anatomy of the tumor vascular bed and the functional vascular properties as detected by dynamic enhanced magnetic resonance imaging. Cancer Res. 2002; 62: 4015-4022.
-
(2002)
Cancer Res
, vol.62
, pp. 4015-4022
-
-
Drevs, J.1
Muller-Driver, R.2
Wittig, C.3
Fuxius, S.4
Esser, N.5
Hugenschmidt, H.6
Konerding, M.A.7
Allegrini, P.R.8
Wood, J.9
Hennig, J.10
Unger, C.11
Marme, D.12
-
16
-
-
30544433266
-
Phase I clinical evaluation of AZD2171, a highly potent VEGF receptor tyrosine kinase inhibitor, in patients with advanced tumors
-
Drevs J, Medinger M, Mross K, Zirrgiebel U, Strecker R, Puchalski T, Fernandes N, Robertson J, Siegert P. Phase I clinical evaluation of AZD2171, a highly potent VEGF receptor tyrosine kinase inhibitor, in patients with advanced tumors. J Clin. Oncol. 2005; 3.
-
(2005)
J Clin. Oncol
, vol.3
-
-
Drevs, J.1
Medinger, M.2
Mross, K.3
Zirrgiebel, U.4
Strecker, R.5
Puchalski, T.6
Fernandes, N.7
Robertson, J.8
Siegert, P.9
-
17
-
-
0347615101
-
-
Morgan B, Thomas AL, Drevs J, Hennig J, Buchert M, Jivan A, Horsfield MA, Mross K, Ball HA, Lee L, Mietlowski W, Fuxuis S, Unger C, O'Byrne K, Henry A, Cherryman GR, Laurent D, Dugan M, Marme D, Steward WP. Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787/ZK 222584,an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases, in patients with advanced colorectal cancer and liver metastases: results from two phase I studies. J Clin Oncol. 2003; 21: 3955-3964.
-
Morgan B, Thomas AL, Drevs J, Hennig J, Buchert M, Jivan A, Horsfield MA, Mross K, Ball HA, Lee L, Mietlowski W, Fuxuis S, Unger C, O'Byrne K, Henry A, Cherryman GR, Laurent D, Dugan M, Marme D, Steward WP. Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787/ZK 222584,an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases, in patients with advanced colorectal cancer and liver metastases: results from two phase I studies. J Clin Oncol. 2003; 21: 3955-3964.
-
-
-
-
18
-
-
33645732568
-
-
Lee L, Sharma S, Morgan B, Allegrini P, Schnell C, Brueggen J, Cozens R, Horsfield M, Guenther C, Steward WP, Drevs J, Lebwohl D, Wood J, McSheehy PM. Biomarkers for assessment of pharmacologic activity for a vascular endothelial growth factor (VEGF) receptor inhibitor, PTK787/ZK 222584 (PTK/ZK): translation of biological activity in a mouse melanoma metastasis model to phase I studies in patients with advanced colorectal cancer with liver metastases. Cancer Chemother. Pharmacol. 2006; 57: 761-771.
-
Lee L, Sharma S, Morgan B, Allegrini P, Schnell C, Brueggen J, Cozens R, Horsfield M, Guenther C, Steward WP, Drevs J, Lebwohl D, Wood J, McSheehy PM. Biomarkers for assessment of pharmacologic activity for a vascular endothelial growth factor (VEGF) receptor inhibitor, PTK787/ZK 222584 (PTK/ZK): translation of biological activity in a mouse melanoma metastasis model to phase I studies in patients with advanced colorectal cancer with liver metastases. Cancer Chemother. Pharmacol. 2006; 57: 761-771.
-
-
-
-
19
-
-
0032853898
-
Key factors in the acquisition of contrast kinetic data for oncology
-
Evelhoch JL. Key factors in the acquisition of contrast kinetic data for oncology. J Magn. Reson. Imaging. 1999; 10: 254-259.
-
(1999)
J Magn. Reson. Imaging
, vol.10
, pp. 254-259
-
-
Evelhoch, J.L.1
-
20
-
-
3042716652
-
Semiquantitative analysis of dynamic contrast enhanced MRI in cancer patients: Variability and changes in tumor tissue over time
-
Medved M, Karczmar G, Yang C, Dignam J, Gajewski TF, Kindler H, Vokes E, MacEneany P, Mitchell MT, Stadler WM. Semiquantitative analysis of dynamic contrast enhanced MRI in cancer patients: Variability and changes in tumor tissue over time. J Magn. Reson. Imaging. 2004; 20: 122-128.
-
(2004)
J Magn. Reson. Imaging
, vol.20
, pp. 122-128
-
-
Medved, M.1
Karczmar, G.2
Yang, C.3
Dignam, J.4
Gajewski, T.F.5
Kindler, H.6
Vokes, E.7
MacEneany, P.8
Mitchell, M.T.9
Stadler, W.M.10
-
21
-
-
0031401415
-
Probing tumor microvascularity by measurement, analysis and display of contrast agent uptake kinetics
-
Parker GJ, Suckling J, Tanner SF, Padhani AR, Revell PB, Husband JE, Leach MO. Probing tumor microvascularity by measurement, analysis and display of contrast agent uptake kinetics. J Magn. Reson. Imaging. 1997; 7: 564-574.
-
(1997)
J Magn. Reson. Imaging
, vol.7
, pp. 564-574
-
-
Parker, G.J.1
Suckling, J.2
Tanner, S.F.3
Padhani, A.R.4
Revell, P.B.5
Husband, J.E.6
Leach, M.O.7
-
22
-
-
0032828135
-
Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: Standardized quantities and symbols
-
Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, Larsson HB, Lee TY, Mayr NA, Parker GJ, Port RE, Taylor J, Weisskoff RM. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn. Reson. Imaging. 1999; 10: 223-232.
-
(1999)
J Magn. Reson. Imaging
, vol.10
, pp. 223-232
-
-
Tofts, P.S.1
Brix, G.2
Buckley, D.L.3
Evelhoch, J.L.4
Henderson, E.5
Knopp, M.V.6
Larsson, H.B.7
Lee, T.Y.8
Mayr, N.A.9
Parker, G.J.10
Port, R.E.11
Taylor, J.12
Weisskoff, R.M.13
-
23
-
-
38949084837
-
Head-to-head comparison of large size contrast agent with GdDOTA (Dotarem) for assessing tumor vascular permeability
-
Allegrini PR, Weidensteiner C, Ferrera P, Ferretti S, McSheehy P. Head-to-head comparison of large size contrast agent with GdDOTA (Dotarem) for assessing tumor vascular permeability. European Society for Magnetic Resonance in Medicine and Biology. 2005; 43-43.
-
(2005)
European Society for Magnetic Resonance in Medicine and Biology
, pp. 43-43
-
-
Allegrini, P.R.1
Weidensteiner, C.2
Ferrera, P.3
Ferretti, S.4
McSheehy, P.5
-
24
-
-
38949209801
-
-
Ferretti S, Allegrini PR, McSheehy P. Correlation between effects of PTK787/ZK222584 on the interstitial fluid pressure of rat mammary tumours and their vasculature measured by contrast enhanced MRI. AACR-NCI-EORTC. 2004.
-
Ferretti S, Allegrini PR, McSheehy P. Correlation between effects of PTK787/ZK222584 on the interstitial fluid pressure of rat mammary tumours and their vasculature measured by contrast enhanced MRI. AACR-NCI-EORTC. 2004.
-
-
-
-
25
-
-
3042719089
-
Tumor microvascular changes in antiangiogenic treatment: Assessment by magnetic resonance contrast media of different molecular weights
-
Turetschek K, Preda A, Novikov V, Brasch RC, Weinmann HJ, Wunderbaldinger P, Roberts TP. Tumor microvascular changes in antiangiogenic treatment: assessment by magnetic resonance contrast media of different molecular weights. J Magn. Reson. Imaging. 2004; 20: 138-144.
-
(2004)
J Magn. Reson. Imaging
, vol.20
, pp. 138-144
-
-
Turetschek, K.1
Preda, A.2
Novikov, V.3
Brasch, R.C.4
Weinmann, H.J.5
Wunderbaldinger, P.6
Roberts, T.P.7
-
26
-
-
0036847258
-
MR angiography with a new rapid-clearance blood pool agent: Initial experience in rabbits
-
Ruehm SG, Christina H, Violas X, Corot C, Debatin JF. MR angiography with a new rapid-clearance blood pool agent: Initial experience in rabbits. Magn. Reson. Med. 2002; 48: 844-851.
-
(2002)
Magn. Reson. Med
, vol.48
, pp. 844-851
-
-
Ruehm, S.G.1
Christina, H.2
Violas, X.3
Corot, C.4
Debatin, J.F.5
-
27
-
-
10744232021
-
Reduced capillary perfusion and permeability in human tumour xenografts treated with the VEGF signalling inhibitor Z D4190:an in vivo assessment using dynamic MR imaging and macromolecular contrast media
-
Pradel C, Siauve N, Bruneteau G, Clement O, de Bazelaire C, Frouin F, Wedge SR, Tessier JL, Robert PH, Frija G, Cuenod CA. Reduced capillary perfusion and permeability in human tumour xenografts treated with the VEGF signalling inhibitor Z D4190:an in vivo assessment using dynamic MR imaging and macromolecular contrast media. Magn. Reson. Imaging. 2003; 21: 845-851.
-
(2003)
Magn. Reson. Imaging
, vol.21
, pp. 845-851
-
-
Pradel, C.1
Siauve, N.2
Bruneteau, G.3
Clement, O.4
de Bazelaire, C.5
Frouin, F.6
Wedge, S.R.7
Tessier, J.L.8
Robert, P.H.9
Frija, G.10
Cuenod, C.A.11
-
28
-
-
0036191012
-
Uncertainty in the analysis of tracer kinetics using dynamic contrast-enhanced T1-weighted MRI
-
Buckley DL. Uncertainty in the analysis of tracer kinetics using dynamic contrast-enhanced T1-weighted MRI. Magn Reson. Med. 2002; 47: 601-606.
-
(2002)
Magn Reson. Med
, vol.47
, pp. 601-606
-
-
Buckley, D.L.1
-
29
-
-
38949169166
-
Incorporation of Explicit Arterial Input Function for DCE-MRI Quantification: Use in Human trial of Sorafenib in Renal Cell Carcinoma
-
Rosen M, Flaherty K, Heitjan D, Schwartz B, O'Dwyer P. Incorporation of Explicit Arterial Input Function for DCE-MRI Quantification: Use in Human trial of Sorafenib in Renal Cell Carcinoma. Proc. Intl. Soc. Mag. Reson. Med. 2006; 14: 2929.
-
(2006)
Proc. Intl. Soc. Mag. Reson. Med
, vol.14
, pp. 2929
-
-
Rosen, M.1
Flaherty, K.2
Heitjan, D.3
Schwartz, B.4
O'Dwyer, P.5
-
31
-
-
0028936695
-
Continuous update with random encoding (CURE): A new strategy for dynamic imaging
-
Parrish T, Hu X. Continuous update with random encoding (CURE): a new strategy for dynamic imaging. Magn. Reson. Med. 1995; 33: 326-336.
-
(1995)
Magn. Reson. Med
, vol.33
, pp. 326-336
-
-
Parrish, T.1
Hu, X.2
-
32
-
-
26944497918
-
Averaging keyhole pulse sequence with presaturation pulses and EXORCYCLE phase cycling for dynamic contrast-enhanced MRI
-
Kuribayashi H, Bradley DP, Checkley DR, Worthington PL, Tessier JJ. Averaging keyhole pulse sequence with presaturation pulses and EXORCYCLE phase cycling for dynamic contrast-enhanced MRI. Magn Reson. Med. Sci. 2004; 3: 207-210.
-
(2004)
Magn Reson. Med. Sci
, vol.3
, pp. 207-210
-
-
Kuribayashi, H.1
Bradley, D.P.2
Checkley, D.R.3
Worthington, P.L.4
Tessier, J.J.5
-
33
-
-
24144472335
-
Quantifying dynamic contrast-enhanced MRI of the knee in children with juvenile rheumatoid arthritis using an arterial input function (AIF) extracted from popliteal artery enhancement, and the effect of the choice of the AIF on the kinetic parameters
-
Workie DW, Dardzinski BJ. Quantifying dynamic contrast-enhanced MRI of the knee in children with juvenile rheumatoid arthritis using an arterial input function (AIF) extracted from popliteal artery enhancement, and the effect of the choice of the AIF on the kinetic parameters. Magn Reson. Med. 2005; 54: 560-568.
-
(2005)
Magn Reson. Med
, vol.54
, pp. 560-568
-
-
Workie, D.W.1
Dardzinski, B.J.2
-
34
-
-
0028395775
-
Simulation of spatial and contrast distortions in keyhole imaging
-
Spraggins TA. Simulation of spatial and contrast distortions in keyhole imaging. Magn. Reson. Med. 1994; 31: 320-322.
-
(1994)
Magn. Reson. Med
, vol.31
, pp. 320-322
-
-
Spraggins, T.A.1
-
35
-
-
34249908085
-
Misregistration artifacts in image-derived arterial input function in dynamic contrast-enhanced MRI
-
in press
-
Kuribayashi H, Worthington P, Bradley D, Checkley D, Tessier JJ, Waterton JC. Misregistration artifacts in image-derived arterial input function in dynamic contrast-enhanced MRI. J Magn Reson. Imaging. 2007; in press.
-
(2007)
J Magn Reson. Imaging
-
-
Kuribayashi, H.1
Worthington, P.2
Bradley, D.3
Checkley, D.4
Tessier, J.J.5
Waterton, J.C.6
-
36
-
-
38949194544
-
Variation of the Arterial Input Function in Myocardial Perfusion Measurements: Influence of ROI size and Position
-
Karg A, Abegunewardene N, Horstick G, Hoffmann N, Kreitner KF, Schreiber WG. Variation of the Arterial Input Function in Myocardial Perfusion Measurements: Influence of ROI size and Position. Proc. Intl. Soc. Mag. Reson. Med. 2003; 11: 1665-1665.
-
(2003)
Proc. Intl. Soc. Mag. Reson. Med
, vol.11
, pp. 1665-1665
-
-
Karg, A.1
Abegunewardene, N.2
Horstick, G.3
Hoffmann, N.4
Kreitner, K.F.5
Schreiber, W.G.6
-
37
-
-
4243061753
-
Morphological evidence for an invasion-independent metastasis pathway exists in multiple human cancers
-
Sugino T, Yamaguchi T, Ogura G, Saito A, Hashimoto T, Hoshi N, Yoshida S, Goodison S, Suzuki T. Morphological evidence for an invasion-independent metastasis pathway exists in multiple human cancers. BMC. Med. 2004; 2: 9.
-
(2004)
BMC. Med
, vol.2
, pp. 9
-
-
Sugino, T.1
Yamaguchi, T.2
Ogura, G.3
Saito, A.4
Hashimoto, T.5
Hoshi, N.6
Yoshida, S.7
Goodison, S.8
Suzuki, T.9
-
38
-
-
0024538346
-
Vascular volume in B16 allografts and human melanoma xenografts estimated by means of Hoechst 33342
-
Fallowfield ME. Vascular volume in B16 allografts and human melanoma xenografts estimated by means of Hoechst 33342. J Pathol. 1989; 157: 249-252.
-
(1989)
J Pathol
, vol.157
, pp. 249-252
-
-
Fallowfield, M.E.1
-
39
-
-
0033782203
-
Determination of the MRI contrast agent concentration time course in vivo following bolus injection: Effect of equilibrium transcytolemmal water exchange
-
Landis CS, Li X, Telang FW, Coderre JA, Micca PL, Rooney WD, Latour LL, Vetek G, Palyka I, Springer CS Jr. Determination of the MRI contrast agent concentration time course in vivo following bolus injection: effect of equilibrium transcytolemmal water exchange. Magn Reson. Med. 2000; 44: 563-574.
-
(2000)
Magn Reson. Med
, vol.44
, pp. 563-574
-
-
Landis, C.S.1
Li, X.2
Telang, F.W.3
Coderre, J.A.4
Micca, P.L.5
Rooney, W.D.6
Latour, L.L.7
Vetek, G.8
Palyka, I.9
Springer Jr., C.S.10
-
40
-
-
3543138424
-
Simultaneous measurement of arterial input function and tumor pharmacokinetics in mice by dynamic contrast enhanced imaging: Effects of transcytolemmal water exchange
-
Zhou R, Pickup S, Yankeelov TE, Springer CS Jr, Glickson JD. Simultaneous measurement of arterial input function and tumor pharmacokinetics in mice by dynamic contrast enhanced imaging: effects of transcytolemmal water exchange. Magn Reson Med. 2004; 52: 248-257.
-
(2004)
Magn Reson Med
, vol.52
, pp. 248-257
-
-
Zhou, R.1
Pickup, S.2
Yankeelov, T.E.3
Springer Jr, C.S.4
Glickson, J.D.5
-
41
-
-
85013312416
-
Tumour angiogenesis: Therapeutic interventions
-
Folkman J. Tumour angiogenesis: Therapeutic interventions. N Engl J Med. 1971; 285: 1182-1186.
-
(1971)
N Engl J Med
, vol.285
, pp. 1182-1186
-
-
Folkman, J.1
-
42
-
-
33646371408
-
-
Burger H, den Bakker MA, Kros JM, van Tol H, de Bruin AM, Oosterhuis W, van den I, van der Harst E, de Schipper HP, Wiemer EA, Nooter K. Activating Mutations in c-KIT and PDGFRa Are Exclusively Found in Gastrointestinal Stromal Tumors and Not in Other Tumors Overexpressing these Imatinib Mesylate Target Genes. Cancer Biol. Ther. 2005; 4:1270-1274.
-
Burger H, den Bakker MA, Kros JM, van Tol H, de Bruin AM, Oosterhuis W, van den I, van der Harst E, de Schipper HP, Wiemer EA, Nooter K. Activating Mutations in c-KIT and PDGFRa Are Exclusively Found in Gastrointestinal Stromal Tumors and Not in Other Tumors Overexpressing these Imatinib Mesylate Target Genes. Cancer Biol. Ther. 2005; 4:1270-1274.
-
-
-
-
43
-
-
10744233010
-
New model for analysis of dynamic contrast-enhanced MRI data distinguishes metastatic from nonmetastatic transplanted rodent prostate tumors
-
Fan X, Medved M, River JN, Zamora M, Corot C, Robert P, Bourrinet P, Lipton M, Culp RM, Karczmar GS. New model for analysis of dynamic contrast-enhanced MRI data distinguishes metastatic from nonmetastatic transplanted rodent prostate tumors. Magn. Reson. Med. 2004; 51: 487-494.
-
(2004)
Magn. Reson. Med
, vol.51
, pp. 487-494
-
-
Fan, X.1
Medved, M.2
River, J.N.3
Zamora, M.4
Corot, C.5
Robert, P.6
Bourrinet, P.7
Lipton, M.8
Culp, R.M.9
Karczmar, G.S.10
-
44
-
-
0038376002
-
Molecular regulation of vessel maturation
-
Jain RK. Molecular regulation of vessel maturation. Nat. Med. 2003; 9: 685-693.
-
(2003)
Nat. Med
, vol.9
, pp. 685-693
-
-
Jain, R.K.1
-
45
-
-
0029047695
-
-
Dvorak HF, Detmar M, Claffey KP, Nagy JA, van de, Water L, Senger DR. Vascular permeability factor/vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflammation. Int Arch Allergy Immunol. 1995; 107: 233-235.
-
Dvorak HF, Detmar M, Claffey KP, Nagy JA, van de, Water L, Senger DR. Vascular permeability factor/vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflammation. Int Arch Allergy Immunol. 1995; 107: 233-235.
-
-
-
-
46
-
-
0042307678
-
Dynamic contrast-enhanced MRI of vascular changes induced by the VEGF-signalling inhibitor ZD4190 in human tumour xenografts
-
Checkley D, Tessier JJ, Wedge SR, Dukes M, Kendrew J, Curry B, Middleton B, Waterton JC. Dynamic contrast-enhanced MRI of vascular changes induced by the VEGF-signalling inhibitor ZD4190 in human tumour xenografts. Magn. Reson. Imaging. 2003; 21: 475-482.
-
(2003)
Magn. Reson. Imaging
, vol.21
, pp. 475-482
-
-
Checkley, D.1
Tessier, J.J.2
Wedge, S.R.3
Dukes, M.4
Kendrew, J.5
Curry, B.6
Middleton, B.7
Waterton, J.C.8
-
47
-
-
2542441515
-
A method for interleaved acquisition of a vascular input function for dynamic contrast-enhanced MRI in experimental rat tumours
-
McIntyre DJ, Ludwig C, Pasan A, Griffiths JR. A method for interleaved acquisition of a vascular input function for dynamic contrast-enhanced MRI in experimental rat tumours. NMR Biomed. 2004; 17: 132-143.
-
(2004)
NMR Biomed
, vol.17
, pp. 132-143
-
-
McIntyre, D.J.1
Ludwig, C.2
Pasan, A.3
Griffiths, J.R.4
-
48
-
-
0033766487
-
Gd-DTPA relaxivity depends on macromolecular content
-
Stanisz GJ, Henkelman RM. Gd-DTPA relaxivity depends on macromolecular content. Magn. Reson. Med. 2000; 44: 665-667.
-
(2000)
Magn. Reson. Med
, vol.44
, pp. 665-667
-
-
Stanisz, G.J.1
Henkelman, R.M.2
-
49
-
-
38949156168
-
Quantitative perfusion measurements of liver metastisis from DCE-MRI using inversion recovery TrueFISP
-
Strecker R, Scheffler K, Hennig J. Quantitative perfusion measurements of liver metastisis from DCE-MRI using inversion recovery TrueFISP. Proc. Intl. Soc. Mag. Reson. Med. 2004; 442.
-
(2004)
Proc. Intl. Soc. Mag. Reson. Med
, pp. 442
-
-
Strecker, R.1
Scheffler, K.2
Hennig, J.3
-
50
-
-
0037406889
-
Automatic calculation of the arterial input function for cerebral perfusion imaging with MR imaging
-
Carroll TJ, Rowley HA, Haughton VM. Automatic calculation of the arterial input function for cerebral perfusion imaging with MR imaging. Radiology. 2003; 227: 593-600.
-
(2003)
Radiology
, vol.227
, pp. 593-600
-
-
Carroll, T.J.1
Rowley, H.A.2
Haughton, V.M.3
|